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Objective: This study reports initial results of partial left ventriculectomy
performed with preservation of the mitral valve in the treatment of 27
patients with idiopathic dilated cardiomyopathy. Methods: Patients were
in New York Heart Association class III or IV. Partial ventriculectomy
was performed as an isolated procedure in four patients and associated
with mitral annuloplasty in 23 patients. There were four hospital deaths
(14.8%) and the remaining patients were followed for 11.2 6 6 months.
Results: Decrease of left ventricular diastolic diameter (81.8 6 8.7 to
68.5 6 7.6 mm, p < 0.001) and improvement of left ventricular wall
shortening (12% 6 3.1% to 18.1% 6 3.9%, p < 0.001) were demonstrated
by echocardiography after the operation. Left ventricular radioisotopic
angiography showed reduction of diastolic volume (495 6 124 ml to
352 6 108 ml, p < 0.001) and increase of ejection fraction (17.7% 6 4.6%
to 23.7% 6 8.8%, p < 0.001). Right-sided heart catheterization demon-
strated improvement of stroke index (24.3 6 7.7 ml/m2 to 28.3 6 7.6
ml/m2, p < 0.01) and decrease of pulmonary wedge pressure (23.2 6 8.8
mm Hg to 17 6 7 mm Hg, p < 0.01). Similar results were documented
at 6 and 12 months of follow-up. Functional class improved from 3.6 6
0.5 to 1.4 6 0.6 (p < 0.001). However, seven patients died at midterm
follow-up because of heart failure progression or arrhythmia-related
events, and survival rate was 59.2% 6 9.4% from 6 to 24 months of
follow-up. Conclusions: Partial left ventriculectomy performed with
preservation of the mitral valve improves left ventricular function and
congestive heart failure in patients with dilated cardiomyopathy. Nev-
ertheless, the high incidences of heart failure progression and arrhyth-
mia-related deaths observed after this procedure preclude its wide
clinical application. (J Thorac Cardiovasc Surg 1998;115:800-7)
Partial left ventriculectomy is a new surgical op-tion introduced by Batista and coworkers1, 2 for
the treatment of end-stage cardiomyopathies. Its
primary objective is the reduction of left ventricular
(LV) wall tension by the decrease of chamber
volume/mass relationship, which is obtained by the
resection of a large portion of LV free wall.
No experimental data exist regarding the benefits of
LV chamber reduction in heart failure models. In
addition, despite the existence of initial clinical reports
of LV function early improvement after partial ventri-
culectomy,3-7 no documentation is found regarding
long-term survival or prolonged benefits after this
procedure in patients with dilated cardiomyopathy.
Accordingly, a prospective study concerning the
effects of partial left ventriculectomy in the treat-
ment of severe cardiomyopathies has been con-
ducted by the Heart Failure and Heart Transplan-
tation Program of the Sa˜o Paulo Heart Institute
since 1995. This report shows the initial results of
this procedure, performed with preservation of the
mitral valve, in the treatment of advanced heart
failure caused by idiopathic dilated cardiomyopathy.
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Methods
Patient population. Entry into the protocol was based
on the existence of significant functional limitation despite
attempts to optimize medical therapy with maximal doses
of diuretics and angiotensin converting enzyme inhibitors
or vasodilators. Patients also had reduced LV function
characterized by radioisotopic ejection fraction # 25%
and persistently high filling pressures. Medical or psycho-
social contraindications to heart transplantation were
present or this procedure was refused by the patients.
They signed a special informed consent form according to
the Ethical and Scientific Review Board of the Heart
Institute.
From April 1995 to December 1996, partial ventricu-
lectomy was performed in 27 patients with idiopathic
dilated cardiomyopathy. The patients’ ages ranged from
33 to 72 years (mean 47.3 years); and 23 patients were
men. Eleven patients were in New York Heart Associa-
tion (NYHA) class III and 16 were in persistent class IV.
The mean duration of symptoms was 4.2 years, and they
had an average of 2.4 hospitalizations for heart failure
treatment in the preceding year. Five of these patients
also had reversible cardiogenic shock with temporary use
of intravenous inotropic drugs.
Preoperative LV ejection fractions ranged from 9% to
25% (mean 17.7%), as documented by radioisotopic
scintigraphy. Patients also had a mean LV end-diastolic
pressure of 24.3 6 9.2 mm Hg and a mean cardiac index
of 2.08 6 0.49 L/min z m2 at heart catheterization. Ab-
sence of significant coronary artery compromise was also
shown in every patient. Mitral valve insufficiency was
present in 23 patients, being moderate in 5 patients and
mild in 18 patients. Five patients also had significant
tricuspid valve insufficiency, being moderate in four pa-
tients and severe in one patient.
Twenty-five patients were in sinus rhythm and the other
two were in atrial fibrillation. Nonsustained ventricular
tachycardia episodes were documented by Holter record-
ings in 16 patients, whereas the occurrence of sustained
ventricular tachycardia not controlled by medical therapy
was considered a contraindication for this operation.
Surgical procedure. Partial left ventriculectomy was
performed as an isolated procedure or associated with
atrioventricular valve annuloplasty. A median sternotomy
approach was used with a standard cardiopulmonary
bypass. All procedures were usually done under normo-
thermia and on the beating heart. De-airing was accom-
plished through the opened left chambers supplemented
by an aortic root suction catheter.
LV volume reduction was performed according to the
technique initially described by Batista et al.1 A slice of
the ventricular myocardium as large as possible was
resected between the papillary muscles from the apex of
the heart up to 2 cm from the mitral anulus as represented
in Fig. 1. Obtuse marginal branches of the circumflex
artery were usually resected with the myocardial speci-
men. The left ventricle was then repaired with a double
3-0 polypropylene suture anchored in bovine pericardium
strips.
Mitral valve annuloplasty was done in the presence of
any degree of mitral regurgitation to avoid the influence
of residual insufficiency and to contribute to LV dimen-
Fig. 1. Schematic representation of partial left ventriculectomy.
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sion decrease. The mitral valve was assessed through the
left atrium, and the mitral anulus was reduced by plication
of the posterior leaflet region with sutures anchored in a
strip of bovine pericardium. The De Vega tricuspid annu-
loplasty was done in patients with moderate to severe
tricuspid regurgitation. Endocardial automatic cardio-
verter-defibrillators were routinely implanted in the last
eight patients after discharge from the intensive care unit.
Follow-up protocol. Patients were clinically evaluated
on a monthly basis during the first 3 months of follow-up
and at least every 6 months afterward. Patients continue
to use diuretics and angiotensin-converting enzyme inhib-
itors or vasodilators with approximately the same doses as
before the operation. Amiodarone was routinely used in
patients who had episodes of sustained ventricular tachy-
cardia or to decrease heart rate in patients with atrial
fibrillation in doses ranging from 200 to 400 mg/day.
Ventricular function was analyzed before the operation,
during the first postoperative month, and at 6 and 12
months of follow-up by means of echocardiography, ra-
dioisotopic scintigraphy, magnet resonance imaging, and
right-sided heart catheterization.
Doppler echocardiography was performed with the
Aloka SSD-730 and SSD-870 sector scans (Aloka Inc.,
Tokyo, Japan). LV end-diastolic and end-systolic diame-
ters were obtained by M-mode and two-dimensional echo-
cardiograms. Percentage of fractional shortening was cal-
culated using standard formulas. The severity of mitral
and tricuspid valve insufficiency was determined by Dopp-
ler analysis.
Radioisotopic scintigraphy was obtained after in vivo
labeling of red blood cells by 99mTc. Gated blood pool
imaging was acquired in the left anterior oblique view with
a Siemens model LEM1 camera (Siemens Corp., Union,
N.J.). The images were analyzed in a Microvax model
3300 computer (Siemens): LV volumes and ejection frac-
tion were calculated without the use of correcting factors
to avoid mitral regurgitation influence.
Noninvasive evaluation of LV function was also done by
magnetic resonance imaging. This study was performed
using a 0.5 T magnet (Phillips, Best, The Netherlands),
with cine magnet resonance imaging sequences to mea-
sure volumes and to calculate ejection fraction.
For right-sided heart catheterization, a thermodilution
balloon-tipped catheter was positioned in the left pulmo-
nary artery. Cardiac output was obtained by the thermodi-
lution technique, whereas arterial pressures were mea-
sured by noninvasive standard means. Cardiac index,
stroke index, left and right ventricular stroke work in-
dexes, and vascular resistances were calculated by stan-
dard formulas.
Statistical analysis. Data were analyzed using the Sta-
tistics Data Analysis Package (Stata Corporation, College
Station, Tex.). Cumulative mortality and event rates over
time were determined by the Kaplan-Meier method, and
differences between them were assessed by the log-rank
test. Repeated measures analysis of variance and Dun-
net’s test were used to compare data obtained before and
after partial left ventriculectomy. Data are presented as
mean 6 standard deviation, whereas survival rates are
presented as mean 6 standard error of the mean. Linear
regression was used to test the relationship between some
variables.
Results
Immediate surgical results. Isolated partial left
ventriculectomy was performed only in four pa-
tients. This procedure was associated with mitral
valve annuloplasty in the remaining 23 patients and
5 of them also underwent the De Vega tricuspid
valve annuloplasty. The resected myocardial speci-
men measured 10.7 6 1.3 cm in length and 4.8 6 0.8
cm in width. All patients were weaned from cardio-
pulmonary bypass with dobutamine and sodium
nitroprusside, and eight patients also required in-
traaortic balloon counterpulsation. Intraoperative
transesophageal echocardiography after discontinu-
ation of bypass revealed no mitral regurgitation in
22 patients and mild regurgitation in 5 patients.
Pharmacologic inotropic support was usually
maintained for 1 week after the operation, and
intraaortic balloon pumping was normally discontin-
ued the second or third postoperative day. One
patient had refractory heart failure and required the
insertion of a centrifugal pump for LV assistance the
second day. Another patient had dehiscence of the
mitral valve annuloplasty and was reoperated for
mitral valve replacement 5 days after the initial
operation.
Six patients (22.2%) had episodes of sustained
ventricular tachycardia reverted by electrical cardio-
version during the first 2 weeks of follow-up. Tran-
Fig. 2. Actuarial survival curve after partial left ventricu-
lectomy. Numbers in parentheses indicate patients at risk
in the follow-up period. Values are presented as mean 6
standard error of the mean.
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sient periods of renal failure developed in four
patients (14.8%), and pulmonary complications oc-
curred in five patients (18.5%). The mean peak
serum level of the myocardial component of the
creatine kinase enzyme was 116 6 58 IU.
Four patients died during the hospitalization pe-
riod (14.8%). The causes of death were cardiogenic
shock associated with restrictive LV dysfunction in
the patient who required mechanical circulatory
support with centrifugal pump; septicemia and car-
diogenic shock in the patient reoperated because of
mitral annuloplasty dehiscence; incessant sustained
ventricular tachycardia in one patient; and bleeding
associated with disseminated intravascular coagula-
tion in another patient.
Midterm follow-up. Twenty-three patients were
discharged from the hospital, and they were fol-
lowed from 2 to 26 months (mean 11.2 months),
corresponding to 265 patient-months. At hospital
discharge, NYHA class improved from 3.6 6 0.5 to
1.4 6 0.6 (p 5 0.001).
During the first 6 months of follow-up, five pa-
tients were rehospitalized because of heart failure
progression and the other two because of sustained
ventricular tachycardia episodes. Four of these pa-
tients were listed for heart transplantation, and this
procedure was urgently done in one of them 7
months after partial left ventriculectomy.
Furthermore, seven patients died at midterm fol-
low-up. The mortality risk was 4.1% per patient-
month, and the survival rates were 66.6% 6 9.1% at
3 months and 59.2% 6 9.4% from 6 to 24 months of
follow-up (Fig. 2). Cause of death was progressive
heart failure in three patients, which was associated
with pulmonary thromboembolism in one of them.
The other four patients died from incessant sus-
tained ventricular tachycardia or suddenly. The in-
cidences of heart failure progression leading to
death or the necessity for urgent heart transplanta-
tion and of arrhythmia-related deaths were 2.2%
and 1.9% per patient-month, respectively. Two of
the patients who had an arrhythmia-related death
were awaiting heart transplantation because of heart
failure decompensation. Three of them had previ-
ous episodes of sustained ventricular tachycardia;
two were taking amiodarone, and one had an auto-
matic internal cardioverter-defibrillator. Besides
one sudden death, another of the eight patients who
received cardioverter-defibrillators died from heart
failure progression, representing a risk of mortality
of 3.7% per patient-month.
On the other hand, the 16 patients who survived
more than 6 months of follow-up maintained signif-
icant clinical improvement. Ten of these patients are
currently in functional class I and six are in class II
(p , 0.001 in relation to preoperative data). Fur-
thermore, only one of them required hospitalization
twice because of heart failure symptoms.
Ventricular function evaluation. Data obtained
by echocardiography, radioisotopic scintigraphy,
and magnetic resonance imaging are shown in Table
I. Significant improvements of LV fractional short-
ening and ejection fraction were documented by the
three methods early after partial ventriculectomy.
These findings occurred in the presence of the
decrease of LV end-diastolic diameter and volume
in the order of 30%. At 6 and 12 months of
follow-up, the results of echocardiography and ra-
Table I. Noninvasive evaluation of LV function
Preoperative
Follow-up
1 mo 6 mo 12 mo
Echocardiography (n 5 23) (n 5 23) (n 5 16) (n 5 10)
LVEDD (mm) 81.8 6 8.7 68.5 6 7.6* 70.2 6 7* 71.1 6 6.6* p , 0.001
LVSWS (%) 12 6 3.1 18.1 6 3.9* 16.4 6 3.5* 16.5 6 5.1* p 5 0.008
Radioisotopic
scintigraphy
(n 5 23) (n 5 23) (n 5 16) (n 5 10)
LVEDV (ml) 495 6 124 352 6 108* 384 6 95* 380 6 70* p 5 0.001
LVEF (%) 17.7 6 4.6 23.7 6 8.8* 24.1 6 8.3* 23.7 6 6 p 5 0.001
Magnetic resonance
imaging
(n 5 20) (n 5 20) (n 5 7)
LVEDV (ml) 371 6 118 272 6 89* 286 6 90* — p ,0.001
LVEF (%) 16.7 6 7.5 29.1 6 9.1* 24.6 6 7.2* — p 5 0.01
LVEDD, Left ventricular end-diastolic diameter; LVSWS, left ventricular segmental wall shortening; LVEDV, left ventricular end-diastolic volume; LVEF,
left ventricular ejection fraction. Numbers in parentheses indicate the patients evaluated at each time. Value of p obtained by analysis of variance in patients
with complete follow-up.
*p , 0.05 in relation to preoperative data of matched patients.
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dioisotopic scintigraphy were approximately the
same. Magnetic resonance imaging also showed
similar data at the 6-month follow-up. Besides these
changes, Doppler echocardiography showed that the
degree of mitral and tricuspid valve insufficiency did
not change in the follow-up period.
Table II displays the data obtained in the hemo-
dynamic studies. Significant improvements of the
cardiac index, stroke index, and LV stroke work
index were found early after the operation, associ-
ated with a significant decrease of mean pulmonary
wedge pressure. Similar results were observed in the
surviving patients at 6 and 12 months of follow-up.
The modifications of LV function after partial
ventriculectomy were comparable only in patients
who underwent this procedure and when it was
associated with mitral valve annuloplasty. No corre-
lation exists between radioisotopic LV ejection frac-
tion changes and the percentage of the myocardium
that was resected or LV end-diastolic volume mod-
ifications as exemplified in Fig. 3, A and B. The
percentage of myocardial resection was based on the
echocardiographic estimation of LV perimeter.
On the other hand, significant improvement of
radioisotopic LV ejection fraction occurred early
after the operation only in patients who survived
long term (18.3% 6 5.1% to 26.5% 6 8.3%, p ,
0.001). This parameter did not change in patients
who died or who had urgent heart transplantation
(17.8% 6 4.7% to 17.1% 6 5.3%). The same trend
was not observed by echocardiographic and mag-
netic resonance studies, and the modifications of
hemodynamic parameters were also more signifi-
cant in patients surviving long term.
Discussion
The key event leading to heart failure is the loss of
a critical quantity of functioning myocardial cells.
Compensatory mechanisms include the activation of
hemodynamic and neurohormonal modifications to
enhance the contractile force of the noninjured
myocardium, preserving cardiac function.8, 9 Never-
theless, these mechanisms introduce important risk
factors. Chamber dilatation increases the internal
ventricular wall stress, leading to accelerated energy
expenditure.9, 10 Furthermore, potential develop-
ment of mitral valve insufficiency may overload the
already dilated left ventricle, compromising the
compensatory remodeling process.11 Limiting or
reversing chamber dilatation is an important thera-
peutic goal in standard medical therapy, the results
of which only show modest effects on LV remodel-
ing, however.8 On the other hand, these concepts
also provide the rationale for operative techniques
to reverse the chamber remodeling process.
Ventricular function changes. This study shows
that partial left ventriculectomy, associated when
necessary with mitral valve annuloplasty, signifi-
cantly improves LV function. The increase of LV
ejection fraction was confirmed by different methods
and occurred combined with significant decreases in
end-diastolic diameters and volume. Significant
modifications of hemodynamic parameters were
also found. More precisely, improvements in cardiac
index, stroke index, and LV stroke work index were
shown in the presence of decreased pulmonary
wedge pressure. Besides these changes, the en-
hancement of LV function after partial ventriculec-
tomy involves modifications in the mechanical prop-
Table II. Hemodynamic evaluation
Preoperative
(n 5 23)
Follow-up
1 mo
(n 5 23)
6 mo
(n 5 16)
12 mo
(n 5 10)
MRAP (mm Hg) 10 6 5.5 7.8 6 4.9 7.5 6 5.4 6.7 6 5.1 p 5 0.12
MPAP (mm Hg) 32.2 6 9.5 29 6 9.3 29.3 6 14.1 24 6 13.6 p 5 0.13
MPWP (mm Hg) 23.2 6 8.8 17 6 7* 19.5 6 9.8 20.4 6 8.6 p 5 0.03
MAP (mm Hg) 78 6 15.3 80.3 6 17.6 88 6 20.4* 83.4 6 22* p , 0.001
CI (L/min z m2) 2.13 6 0.54 2.5 6 0.58* 2.63 6 0.4* 2.6 6 0.5* p 5 0.007
SI (ml/m2) 24.3 6 7.7 28.3 6 7.7* 33.1 6 6.4* 33 6 6.9* p 5 0.006
LVSWI (gm z m/m2) 19.7 6 9.1 26.1 6 9.9* 33 6 10.5* 31.1 6 7.9* p , 0.001
PVR (dyne z sec z cm25) 197 6 144 228 6 152 177 6 101 127 6 52 p 5 0.33
MRAP, Mean right atrial pressure; MPAP, mean pulmonary artery pressure; MPWP, mean pulmonary wedge pressure; MAP, mean arterial pressure; CI,
cardiac index; SI, stroke index, LVSWI, left ventricular stroke work index; PVR, pulmonary vascular resistance. Numbers in parentheses indicate the patients
evaluated at each time. Value of p obtained by analysis of variance in patients with complete follow-up.
*p , 0.05 in relation to preoperative data of matched patients.
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erties of the failing heart, as observed in another
study performed in 11 patients of the current pop-
ulation.3 Significant reductions of LV end-systolic
and end-diastolic stresses were demonstrated at the
first month of follow-up by the determination of
pressure-volume loops. Moreover, that study docu-
mented the increase of maximal elastance and de-
creases in end-diastolic pressure and in muscle and
chamber stiffness after the operation.
Improvement of the contractile characteristics of
the failing myocardium has been also observed after
other operative interventions. Dynamic cardiomyo-
plasty is responsible for modifications in hemody-
namic and mechanical parameters of LV function
comparable to those documented in this investiga-
tion.12-14 Another method that can result in im-
proved myocardial contractility and reversion of
chamber dilatation is the chronic use of mechanical
assist devices. The continuous ventricular chamber
unloading obtained with this procedure may lead to
a marked reduction in myocytolysis and to an en-
hanced pressure-volume relationship at the time of
the device explantation.15, 16
Maintenance of LV function improvement for up
to 12 months after partial ventriculectomy in this
series appears to indicate that heart failure stops
progressing in the surviving patients, as similarly
documented with dynamic cardiomyoplasty.14 Nev-
ertheless, longer term follow-up will be necessary to
confirm the existence of prolonged benefits.
Influence of technical aspects. Several issues ex-
ist regarding partial left ventriculectomy technical
aspects. Nevertheless, this series shows that a signif-
icant reduction of LV cavity size was obtained in
patients with dilated cardiomyopathy, performing
the myocardium resection without papillary muscle
resection or translocation. Although other authors
advocate a more aggressive approach regarding the
myocardial resection, with the necessity of associ-
ated mitral valve replacement or papillary muscles
translocation in more than 30% of their cases,
similar results have been described in those series in
relation to ventricular function modifications.2, 5, 6
Furthermore, this study showed the absence of
correlation between LV ejection fraction changes
and the degree of myocardium resection or the level
of LV end-diastolic volume reduction.
The impact of mitral valve reconstruction and its
association with partial left ventriculectomy remains
uncertain. The isolated correction of severe mitral
regurgitation by means of remodeling annuloplasty
is responsible for significant modifications in LV
function. Improvement of LV ejection fraction was
documented after that procedure by echocardiogra-
phy in 16 patients with dilated cardiomyopathy in
the presence of slight modification of LV end-
diastolic volume.17 This finding was also associated
with a favorable clinical outcome with a 1-year
actuarial survival of 75%. On the other hand, al-
though the changes in ejection fraction in the cur-
rent study were similar to those obtained with
isolated mitral valve reconstruction, most of our
patients had only mild or moderate mitral regurgi-
tation before the operation, justifying a less substan-
Fig. 3. A, Plots of radioisotopic LV ejection fraction (L.V.E.F.) variations after partial left ventriculectomy
in relation to the percentage of left ventricular (L.V.) myocardial resection. B, Plots of radioisotopic left LV
ejection fraction (L.V.E.F.) variations after partial left ventriculectomy in relation to LV diastolic volume
(L.V.D.V.) reduction.
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tial impact of mitral annuloplasty on LV function.
Moreover, three patients who only had partial left
ventriculectomy in this series also showed important
ejection fraction improvement (from 18.1% 6 3.9%
to 25.2% 6 11.2%). Accordingly, the mechanisms of
action of these procedures may be complementary
and their association with the treatment of patients
with mitral regurgitation caused by dilated cardio-
myopathies is justified.
Functional improvement and survival. The im-
provement of LV function after partial ventriculec-
tomy seems to be responsible for the amelioration of
patients’ functional class, which agrees with the
general clinical experience with this procedure.2, 4, 5
Most of our surviving patients were in NYHA class
I or II for more than a year of follow-up, and the
number of hospitalizations per patient per year also
decreased.
Nevertheless, clinical improvement occurred only
in a percentage of patients undergoing partial left
ventriculectomy. Immediate and early mortalities
after this procedure were high and occurred because
of heart failure progression or arrhythmia-related
events. The same situation was observed in Batista’s
experience, 2 although the existence of different
causes and other associated procedures makes com-
parison less accurate.
Absence of significant LV function improvement
after partial left ventriculectomy (radioisotopic ejec-
tion fraction increases of less than 10%) occurred in
33% of the patients in this series and was associated
with increased mortality or necessity of urgent heart
transplantation during the first 6 months of follow-
up. Similar findings were observed by Starling and
colleagues that showed the necessity of heart trans-
plantation or mechanical circulatory support in
more than 20% of their patients in the first postop-
erative months.5, 6 Also important is the fact that
either patients who died because of heart failure
progression or an arrhythmia-related event had lack
of LV function improvement immediately after the
operation in this series.
On the other hand, the elevated incidence of
ventricular arrhythmias after partial left ventriculec-
tomy seems to involve mechanisms related to the
procedure itself. The existence of areas of fibrosis
and myocardial infarction around the ventricular
scar may modify the electrophysiologic substrate
leading to ventricular arrhythmias in dilated cardio-
myopathy patients,18 perhaps by new reentrant
pathways. The early introduction of antiarrhythmic
drugs or the implantation of automatic cardioverter-
defibrillators could decrease this complication or its
consequences. The reduction of the incidence of
sudden cardiac death in patients waiting for heart
transplantation is described by some authors with
these procedures.19, 20 However, three of the five
patients who died suddenly or as a result of reen-
trant sustained ventricular tachycardia in this series
were taking amiodarone or had an automatic car-
dioverter-defibrillator.
The important early incidence of heart failure
progression and arrhythmia-related deaths observed
by several authors after partial left ventriculectomy
clearly indicates the necessity of identifying the
determinants of unfavorable outcome. However, the
cohort of patients in this study is too small to
perform any formal prognostic factor analysis, and
there is not any other report demonstrating factors
associated with the adverse results of this procedure.
Otherwise, the absence of significant modifications
in radioisotopic LV ejection fraction and hemody-
namic parameters observed in patients who did not
survive long term in this series is an important
finding in identifying patients who need heart trans-
plantation after partial left ventriculectomy.
A possible reason to have an absence of improved
myocardial contractility in response to LV volume
reduction in patients with severe cardiomyopathies
may be related to the condition of the myocardial
cells. Compensatory mechanisms of heart failure
can cause irreversible structural remodeling of the
heart because of slippage and elongation of myocar-
dial fibers.9 These findings are, however, difficult to
identify by standard methods. Otherwise, evaluation
of myocardium specimens obtained by endomyocar-
dial biopsy by use of refined histologic and histo-
chemical examinations may potentially contribute to
separate out these failures.
Study limitations. This study has several limita-
tions, but it is the first to analyze the possible impact
of partial left ventriculectomy in the treatment of
severe heart failure caused by idiopathic dilated
cardiomyopathy. Although the association of this
procedure with mitral valve annuloplasty in most of
our patients precluded definitive conclusions about
its value, the significant improvement of LV func-
tion documented for up to 12 months of follow-up is
remarkable and very encouraging.
The absence of a matched group of patients
managed medically impeded any judgment about
the safety and benefits of partial left ventriculec-
tomy. The elevated mortality observed in this study,
however, indicates that institutions investigating this
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procedure should provide postoperative access to
alternate options of treatment, including heart
transplantation and mechanical circulatory support,
for all patients. A more aggressive use of mechanical
ventricular assist devices as bridges to heart trans-
plantation could yield a decrease in mortality in the
immediate and early postoperative periods as dem-
onstrated by Starling and coworkers.5, 6
Conclusions
Despite many controversies about this operative
procedure, this investigation demonstrated that par-
tial left ventriculectomy, performed with preserva-
tion of the mitral valve, improves LV function in
patients with idiopathic dilated cardiomyopathy. Al-
though this procedure seems to ameliorate heart
failure symptoms in the surviving patients, the high
incidence of heart failure progression and arrhyth-
mia-related deaths in the early postoperative period
precludes its wide clinical application. However,
further studies need to be conducted to improve
technical aspects, immediate postoperative manage-
ment, and proper patient selection for partial left
ventriculectomy. The effective management of post-
operative ventricular arrhythmias and the long-term
outcome of patients who survive the early postoper-
ative period are also points that need to be ad-
dressed by future investigations.
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